Shaping the Future of Pharmacy Leadership Through Complementary Perspectives at UNC Health
Two pharmacy leaders at UNC Health share how their distinct yet complementary leadership journeys and skill sets are driving innovation…
Championing the Role of Oncology Pharmacists in Patient-Centered Cancer Care
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, FASTCT, discusses the collaborative culture, research opportunities, and leadership pathways that define oncology pharmacy…
Unlocking the Full Potential of Pharmacists in Medication Safety
Maximizing pharmacists’ impact on medication safety requires removing barriers to intervention and empowering proactive clinical roles.
Vizz Becomes First, Only FDA-Approved Aceclidine-Based Eye Drop for Presbyopia
The FDA approves aceclidine ophthalmic solution 1.44%, the first aceclidine eye drop for presbyopia, offering a new solution for millions…
Inclisiran Receives FDA Approval for New Indication to Treat Hypercholesterolemia
FDA approves inclisiran as a monotherapy to effectively lower low-density lipoprotein cholesterol in adults with hypercholesterolemia, enhancing heart disease prevention…
FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use
The approval builds upon concizumab’s previous December 2024 clearance and allows for treatment in patients with hemophilia A or B,…
Study: Exposure to Trihalomethane Concentrations Increases CKD Risk
The authors note that the findings can have significant public health implications given the widespread water chlorination and increased chronic…
Barriers to Accessing TKIs in CML
A panelist discusses how accessing tyrosine kinase inhibitors for chronic myeloid leukemia treatment faces multiple barriers including financial challenges from…
SAR446523 Granted Orphan Drug Designation for Patients With Relapsed, Refractory Multiple Myeloma
Sanofi’s SAR446523 receives orphan drug designation for relapsed refractory multiple myeloma, enhancing treatment options and patient outcomes.